The A-share market has exhibited robust momentum lately, witnessing a surge in multiple stock prices, with many doubling in value. As of August 14, 323 A-shares have doubled their prices within the year. Notably, over 60% of these stocks are heavily invested in by public funds. For instance, companies like Shenghong Technology, YPH, and Hotgen Biotech have attracted investments from more than 50 funds each. Public funds generally remain optimistic about the market outlook, with a particular focus on sectors like technological innovation, pharmaceuticals, and biology.
